|
US5780222A
(en)
|
1995-04-10 |
1998-07-14 |
Alpha Therapeutic Corporation |
Method of PCR testing of pooled blood samples
|
|
WO1998016201A1
(en)
*
|
1996-10-11 |
1998-04-23 |
Sequus Pharmaceuticals, Inc. |
Therapeutic liposome composition and method
|
|
US20020115609A1
(en)
*
|
1997-07-14 |
2002-08-22 |
Hayat Onyuksel |
Materials and methods for making improved micelle compositions
|
|
US20050025819A1
(en)
*
|
1997-07-14 |
2005-02-03 |
Hayat Onyuksel |
Materials and methods for making improved micelle compositions
|
|
US6372720B1
(en)
|
1998-02-05 |
2002-04-16 |
Kenneth J. Longmuir |
Liposome fusion and delivery vehicle
|
|
US6406693B1
(en)
|
1998-07-13 |
2002-06-18 |
Board Of Regents, The University Of Texas System |
Cancer treatment methods using antibodies to aminophospholipids
|
|
US6818213B1
(en)
|
1998-07-13 |
2004-11-16 |
Board Of Regents, The University Of Texas System |
Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids
|
|
BR9912053A
(pt)
*
|
1998-07-13 |
2001-04-03 |
Univ Texas |
Processos de tratamento de câncer utilizando conjugados terapêuticos que se ligam a aminofosfolipìdios
|
|
EP1096955B9
(en)
|
1998-07-13 |
2006-07-05 |
Board of Regents, The University of Texas System |
Uses of antibodies to aminophospholipids for cancer treatment
|
|
US6379698B1
(en)
*
|
1999-04-06 |
2002-04-30 |
Isis Pharmaceuticals, Inc. |
Fusogenic lipids and vesicles
|
|
WO2000062813A2
(en)
*
|
1999-04-20 |
2000-10-26 |
The University Of British Columbia |
Cationic peg-lipids and methods of use
|
|
HUP0201425A3
(en)
|
1999-04-23 |
2006-07-28 |
Hadasit Med Res Service |
Conjugate having a cleavable linkage for use in a liposome
|
|
US7238368B2
(en)
|
1999-04-23 |
2007-07-03 |
Alza Corporation |
Releasable linkage and compositions containing same
|
|
US7303760B2
(en)
|
1999-04-23 |
2007-12-04 |
Alza Corporation |
Method for treating multi-drug resistant tumors
|
|
US7390780B2
(en)
*
|
1999-04-23 |
2008-06-24 |
Alza Corporation |
Gene delivery mediated by liposome-DNA complex with cleavable peg surface modification
|
|
US7112337B2
(en)
|
1999-04-23 |
2006-09-26 |
Alza Corporation |
Liposome composition for delivery of nucleic acid
|
|
AUPQ014699A0
(en)
*
|
1999-05-04 |
1999-05-27 |
Access Pharmaceuticals Australia Pty Limited |
Amplification of folate-mediated targeting to tumor cells using nanoparticles
|
|
WO2001041738A2
(en)
*
|
1999-12-10 |
2001-06-14 |
Celator Technologies Inc. |
Lipid carrier compositions with protected surface reactive functions
|
|
US20060177416A1
(en)
|
2003-10-14 |
2006-08-10 |
Medivas, Llc |
Polymer particle delivery compositions and methods of use
|
|
AU2002225878A1
(en)
*
|
2000-11-02 |
2002-05-15 |
Smith Kline Beecham Corporation |
Receptor antagonist-lipid conjugates and delivery vehicles containing same
|
|
CA2435287A1
(en)
*
|
2001-01-17 |
2002-07-25 |
Zycos Inc. |
Nucleic acid delivery formulations
|
|
HUP0303616A3
(en)
*
|
2001-03-26 |
2006-07-28 |
Alza Corp Mountain View |
Liposome composition for improved intracellular delivery of a therapeutic agent
|
|
WO2002078672A2
(en)
*
|
2001-03-30 |
2002-10-10 |
Alza Corporation |
Liposomal tumor necrosis factor compositions and methods
|
|
US20040126900A1
(en)
*
|
2001-04-13 |
2004-07-01 |
Barry Stephen E |
High affinity peptide- containing nanoparticles
|
|
JP2005527639A
(ja)
|
2001-11-02 |
2005-09-15 |
インサート セラピューティクス インコーポレイテッド |
Ｒｎａ干渉の治療的利用のための方法及び組成物
|
|
US20040219201A1
(en)
*
|
2001-12-06 |
2004-11-04 |
Yechezkel Barenholz |
Tempamine compositions and methods of use
|
|
US20040147466A1
(en)
*
|
2002-01-17 |
2004-07-29 |
Barman Shikha P. |
Nucleic acid delivery formulations
|
|
DE10207178A1
(de)
*
|
2002-02-19 |
2003-09-04 |
Novosom Ag |
Komponenten für die Herstellung amphoterer Liposomen
|
|
US7211250B2
(en)
|
2002-07-18 |
2007-05-01 |
Helix Biopharma Corporation |
Method and composition for inhibiting cancer cell growth
|
|
US20040161468A1
(en)
*
|
2002-12-04 |
2004-08-19 |
L'oreal |
Stabilization of aromatic active principles using aromatic polymers
|
|
FR2848101B1
(fr)
*
|
2002-12-04 |
2006-08-11 |
Oreal |
Procede de traitement cosmetique des matieres keratiniques impliquant la liberation controlee de principes actifs aromatiques a partir de particules de polymere aromatique
|
|
CA2510780A1
(en)
*
|
2002-12-19 |
2004-07-08 |
Alza Corporation |
Method of treating angiogenic tissue growth
|
|
ATE512674T1
(de)
|
2003-01-06 |
2011-07-15 |
Angiochem Inc |
Angiopep-1, verwandte verbindungen, und deren verwnedungen
|
|
WO2004087097A2
(en)
*
|
2003-03-31 |
2004-10-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Stable liposomes or micelles comprising a sphinolipid and a peg-lipopolymer
|
|
US20060115523A1
(en)
*
|
2004-12-01 |
2006-06-01 |
Konduri Kameswari S |
Sterically stabilized liposome and triamcinolone composition for treating the respiratory tract of a mammal
|
|
US11324698B2
(en)
|
2003-08-28 |
2022-05-10 |
Vgsk Technologies, Inc. |
Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating the respiratory tract of a mammal
|
|
US8846079B1
(en)
|
2004-12-01 |
2014-09-30 |
Vgsk Technologies, Inc. |
Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating the respiratory tract of a mammal
|
|
IL158599A0
(en)
*
|
2003-10-26 |
2004-05-12 |
Yeda Res & Dev |
Methods of modulating hematopoiesis
|
|
US7208174B2
(en)
*
|
2003-12-18 |
2007-04-24 |
Hoffmann-La Roche Inc. |
Liposome compositions
|
|
EP1737487B1
(en)
*
|
2004-03-30 |
2016-05-25 |
Canadian Blood Services |
Method for treating autoimmune diseases with antibodies
|
|
ZA200609638B
(en)
*
|
2004-04-21 |
2008-02-27 |
Alza Corp |
Polymer conjugate releasable under mild thiolytic conditions
|
|
US20050281798A1
(en)
*
|
2004-06-16 |
2005-12-22 |
Glen Gong |
Targeting sites of damaged lung tissue using composition
|
|
US7553810B2
(en)
*
|
2004-06-16 |
2009-06-30 |
Pneumrx, Inc. |
Lung volume reduction using glue composition
|
|
US20050281799A1
(en)
|
2004-06-16 |
2005-12-22 |
Glen Gong |
Targeting damaged lung tissue using compositions
|
|
US20050281739A1
(en)
*
|
2004-06-16 |
2005-12-22 |
Glen Gong |
Imaging damaged lung tissue using compositions
|
|
US7608579B2
(en)
*
|
2004-06-16 |
2009-10-27 |
Pneumrx, Inc. |
Lung volume reduction using glue compositions
|
|
US7678767B2
(en)
|
2004-06-16 |
2010-03-16 |
Pneumrx, Inc. |
Glue compositions for lung volume reduction
|
|
US20050281740A1
(en)
*
|
2004-06-16 |
2005-12-22 |
Glen Gong |
Imaging damaged lung tissue
|
|
CA2570261C
(en)
*
|
2004-07-08 |
2014-06-10 |
Pneumrx, Inc. |
Pleural effusion treatment device, method and material
|
|
AU2005281352B2
(en)
*
|
2004-09-09 |
2011-01-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Liposomal compositions of glucocorticoid and glucocorticoid derivatives
|
|
US20080063702A1
(en)
*
|
2004-09-09 |
2008-03-13 |
Yechezkel Barenholz |
Liposomal Formulations Comprising an Amphipathic Weak Base Like Tempamine for Treatment of Neurodegenerative Conditions
|
|
US6998028B1
(en)
*
|
2004-09-24 |
2006-02-14 |
Superpower, Inc. |
Methods for forming superconducting conductors
|
|
TW200612993A
(en)
*
|
2004-10-08 |
2006-05-01 |
Alza Corp |
Lipopolymer conjugates
|
|
TW200618820A
(en)
*
|
2004-11-05 |
2006-06-16 |
Alza Corp |
Liposome formulations of boronic acid compounds
|
|
AU2005303389A1
(en)
*
|
2004-11-15 |
2006-05-18 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Combination therapy associating preferably a ceramide with a cytotoxic drug
|
|
MX2007010113A
(es)
*
|
2005-02-18 |
2007-12-07 |
Angiochem Inc |
Polipeptidos de aprotinina para transportar un compuesto a traves de la barrera hematoencefalica.
|
|
US20090016959A1
(en)
*
|
2005-02-18 |
2009-01-15 |
Richard Beliveau |
Delivery of antibodies to the central nervous system
|
|
WO2007005754A2
(en)
*
|
2005-07-01 |
2007-01-11 |
Alza Corporation |
Liposomal delivery vehicle for hydrophobic drugs
|
|
PL2233156T3
(pl)
|
2005-07-15 |
2013-09-30 |
Angiochem Inc |
Zastosowanie polipeptydów aprotyninowych jako nośników w koniugatach farmaceutycznych
|
|
US8591457B2
(en)
*
|
2005-08-10 |
2013-11-26 |
Alza Corporation |
Method for making a needle-free jet injection drug delivery device
|
|
WO2007038246A2
(en)
|
2005-09-22 |
2007-04-05 |
Medivas, Llc |
Solid polymer delivery compositions and methods for use thereof
|
|
CA2623198C
(en)
|
2005-09-22 |
2014-08-05 |
Medivas, Llc |
Bis-(a-amino)-diol-diester-containing poly(ester amide) and poly(ester urethane) compositions and methods of use
|
|
US20090099031A1
(en)
*
|
2005-09-27 |
2009-04-16 |
Stemmer Willem P |
Genetic package and uses thereof
|
|
AU2006294644A1
(en)
*
|
2005-09-27 |
2007-04-05 |
Amunix, Inc. |
Proteinaceous pharmaceuticals and uses thereof
|
|
US7855279B2
(en)
*
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
|
US7846445B2
(en)
*
|
2005-09-27 |
2010-12-07 |
Amunix Operating, Inc. |
Methods for production of unstructured recombinant polymers and uses thereof
|
|
CN101365424A
(zh)
*
|
2005-12-08 |
2009-02-11 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
通过超声辐射改变脂质体组成的方法
|
|
US8067380B2
(en)
|
2005-12-19 |
2011-11-29 |
Industrial Technology Research Institute |
Glutathione-based delivery system
|
|
US7446096B2
(en)
*
|
2005-12-19 |
2008-11-04 |
Industrial Technology Research Institute |
Glutathione based delivery system
|
|
CA2841386A1
(en)
|
2005-12-30 |
2007-07-12 |
Zensun (Shanghai) Science & Technology Limited |
Extended release of neuregulin for improved cardiac function
|
|
US8597636B2
(en)
*
|
2006-01-13 |
2013-12-03 |
Canadian Blood Services |
Method for treating autoimmune diseases and compositions therefor
|
|
US20070218116A1
(en)
*
|
2006-03-14 |
2007-09-20 |
Schwendener Reto A |
Compositions and methods for the treatment of tumors and tumor metastases
|
|
DE102007004303A1
(de)
*
|
2006-08-04 |
2008-02-07 |
Osram Opto Semiconductors Gmbh |
Dünnfilm-Halbleiterbauelement und Bauelement-Verbund
|
|
US20090054317A1
(en)
*
|
2006-08-14 |
2009-02-26 |
Kane Ravindra S |
Polyvalent inhibitors of pathogens
|
|
WO2008026781A1
(en)
*
|
2006-08-31 |
2008-03-06 |
Astellas Pharma Inc. |
Reverse targeting lipid vesicle
|
|
US20100297218A1
(en)
*
|
2006-09-20 |
2010-11-25 |
Pneumrx, Inc. |
Tissue adhesive compositions and methods thereof
|
|
US9365634B2
(en)
|
2007-05-29 |
2016-06-14 |
Angiochem Inc. |
Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
|
|
WO2009006311A2
(en)
*
|
2007-06-29 |
2009-01-08 |
Wisconsin Alumni Research Foundation |
Structuring effect of cholesterol in peg-phospholipid micelles, drug delivery of amphotericin b, and combination antifungals
|
|
CA2695374A1
(en)
*
|
2007-08-15 |
2009-02-19 |
Amunix, Inc. |
Compositions and methods for modifying properties of biologically active polypeptides
|
|
TW200918099A
(en)
*
|
2007-09-14 |
2009-05-01 |
Nitto Denko Corp |
Drug carriers
|
|
JP2011520769A
(ja)
*
|
2007-09-21 |
2011-07-21 |
サイトイミューン サイエンシズ インコーポレイテッド |
ナノ治療コロイド金属組成物および方法
|
|
WO2009076323A2
(en)
|
2007-12-06 |
2009-06-18 |
Genalyte Inc. |
Monitoring enzymatic process
|
|
CN102026667B
(zh)
*
|
2008-04-18 |
2014-06-25 |
安吉奥开米公司 |
紫杉醇、紫杉醇类似物或紫杉醇结合物的药物组合物及相关制备方法和用途
|
|
US8231895B2
(en)
|
2008-05-22 |
2012-07-31 |
Universidade De Coimbra |
Targeted delivery to human diseases and disorders
|
|
US8239357B1
(en)
*
|
2008-09-12 |
2012-08-07 |
Ryan, LLC |
Method and system for extracting information from electronic data sources
|
|
WO2010043047A1
(en)
|
2008-10-15 |
2010-04-22 |
Angiochem Inc. |
Conjugates of glp-1 agonists and uses thereof
|
|
US8828925B2
(en)
|
2008-10-15 |
2014-09-09 |
Angiochem Inc. |
Etoposide and doxorubicin conjugates for drug delivery
|
|
EP2347247B1
(en)
|
2008-10-27 |
2019-06-26 |
Genalyte, Inc. |
Biosensors based on optical probing and sensing
|
|
WO2010063122A1
(en)
*
|
2008-12-05 |
2010-06-10 |
Angiochem Inc. |
Conjugates of neurotensin or neurotensin analogs and uses thereof
|
|
EP2373789A4
(en)
|
2008-12-17 |
2012-08-29 |
Angiochem Inc |
MEMBRANTYP-1 MATRIX METALLOPROTEINASE INHIBITORS AND THEIR USE
|
|
AU2009337181A1
(en)
*
|
2009-01-15 |
2011-08-04 |
Board Of Regents Of The University Of Texas System |
Porous structures with modified biodegradation kinetics
|
|
DK3178835T3
(da)
|
2009-02-03 |
2019-06-24 |
Amunix Pharmaceuticals Inc |
Forlængede rekombinante polypeptider og sammensætninger omfattende samme
|
|
DE102009012640A1
(de)
*
|
2009-03-09 |
2010-09-30 |
Freie Universität Berlin |
Mit einer Phosphoamidatgruppe modifizierte Verbindung und deren Verwendung
|
|
RU2011146654A
(ru)
|
2009-04-20 |
2013-05-27 |
Ангиокем Инк. |
Способы лечения рака яичников с применением конъюгированного средства
|
|
WO2010144508A1
(en)
|
2009-06-08 |
2010-12-16 |
Amunix Operating Inc. |
Glucose-regulating polypeptides and methods of making and using same
|
|
PE20121539A1
(es)
|
2009-06-08 |
2012-12-06 |
Amunix Operating Inc |
Polipeptidos de la hormona de crecimiento y metodos de preparacion
|
|
WO2010143193A1
(en)
|
2009-06-11 |
2010-12-16 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Targeted liposomes comprising n-containing bisphosphonates and uses thereof
|
|
WO2011000095A1
(en)
|
2009-07-02 |
2011-01-06 |
Angiochem Inc. |
Multimeric peptide conjugates and uses thereof
|
|
CA2771999A1
(en)
|
2009-08-24 |
2011-03-10 |
Amunix Operating Inc. |
Coagulation factor vii compositions and methods of making and using same
|
|
BR112012009801A8
(pt)
|
2009-10-30 |
2016-08-30 |
Cns Therapeutics Inc |
Polipeptídeo neurturina e variante de neurturina
|
|
TWI397428B
(zh)
*
|
2009-12-29 |
2013-06-01 |
財團法人工業技術研究院 |
標的第四介白素受體之傳輸系統
|
|
WO2011092708A2
(en)
|
2010-02-01 |
2011-08-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Liposomes comprising amphipathic drugs and method for their preparation
|
|
EP2635710B1
(en)
|
2010-11-05 |
2017-08-09 |
Genalyte, Inc. |
Optical analyte detection systems and methods of use
|
|
US9873765B2
(en)
|
2011-06-23 |
2018-01-23 |
Dsm Ip Assets, B.V. |
Biodegradable polyesteramide copolymers for drug delivery
|
|
ES2558357T3
(es)
|
2011-06-23 |
2016-02-03 |
Dsm Ip Assets B.V. |
Micro- o nanopartículas que comprenden un copolímero de poliesteramida biodegradable para uso en el suministro de agentes bioactivos
|
|
LT2731591T
(lt)
|
2011-07-13 |
2020-12-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Liposomos, kuriose kartu inkapsuliuotas bisfosfonatas ir amfipatinis agentas
|
|
WO2013114377A1
(en)
|
2012-02-02 |
2013-08-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd |
Stable liposomes for drug delivery
|
|
CN111548418A
(zh)
|
2012-02-15 |
2020-08-18 |
比奥贝拉蒂治疗公司 |
因子viii组合物及其制备和使用方法
|
|
WO2013123457A1
(en)
|
2012-02-15 |
2013-08-22 |
Biogen Idec Ma Inc. |
Recombinant factor viii proteins
|
|
US20130261010A1
(en)
|
2012-03-12 |
2013-10-03 |
The Board Of Trustees Of The University Of Illinois |
Optical analyte detection systems with magnetic enhancement and methods of use
|
|
US9156897B2
(en)
|
2012-06-08 |
2015-10-13 |
Alkermes, Inc. |
Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide
|
|
CN102920658B
(zh)
*
|
2012-11-02 |
2015-01-21 |
艾韦特(溧阳)医药科技有限公司 |
与glp-1类似物和聚乙二醇结合的脂质体及其制备方法
|
|
US10548953B2
(en)
|
2013-08-14 |
2020-02-04 |
Bioverativ Therapeutics Inc. |
Factor VIII-XTEN fusions and uses thereof
|
|
BR112016011195A2
(pt)
|
2013-11-18 |
2017-09-19 |
Rubius Therapeutics Inc |
Células eritroides enucleadas e seus métodos de fabricação, composição farmacêutica e seu uso, uso de uma população de células eritroides, biorreator, mistura de células e dispositivo médico
|
|
EA201691111A1
(ru)
|
2014-01-10 |
2017-01-30 |
Байоджен Ма Инк. |
Химерные белки фактора viii и их применение
|
|
CN107124869B
(zh)
|
2014-03-25 |
2022-04-01 |
美国政府陆军部 |
包含含有单磷酰脂质a（mpla）的脂质体组合物和皂苷的无毒佐剂制剂
|
|
US20170173005A1
(en)
|
2014-03-27 |
2017-06-22 |
Research Foundation Of The City University Of New York |
Method for detecting or treating triple negative breast cancer
|
|
CN106456744A
(zh)
|
2014-04-01 |
2017-02-22 |
鲁比厄斯治疗法股份有限公司 |
用于免疫调节的方法和组合物
|
|
CA2969171C
(en)
|
2014-12-18 |
2023-12-12 |
Dsm Ip Assets B.V. |
Drug delivery system for delivery of acid sensitive drugs
|
|
EP3261678B8
(en)
|
2015-01-23 |
2021-03-17 |
Helix Biopharma Corp. |
Antibody-urease conjugates for therapeutic purposes
|
|
AU2016233143B2
(en)
|
2015-03-17 |
2021-03-25 |
Alberto Gabizon |
Methods for the treatment of bladder cancer
|
|
EP3307326B9
(en)
|
2015-06-15 |
2021-02-24 |
Angiochem Inc. |
Methods for the treatment of leptomeningeal carcinomatosis
|
|
UA126016C2
(uk)
|
2015-08-03 |
2022-08-03 |
Біовератів Терапеутікс Інк. |
Злитий білок фактора іх
|
|
CN108289845A
(zh)
|
2015-09-14 |
2018-07-17 |
维吉思康科技公司 |
皮下、舌下和口服治疗用空间稳定载体、用于治疗哺乳动物的组合物和方法
|
|
IL286493B
(en)
|
2015-11-06 |
2022-07-01 |
Memorial Sloan Kettering Cancer Center |
Triterpene saponin analogues, methods of producing same, compositions comprising same and uses thereof
|
|
KR20190090827A
(ko)
|
2016-12-02 |
2019-08-02 |
바이오버라티브 테라퓨틱스 인크. |
키메라 응고 인자를 사용해 혈우병성 관절증을 치료하는 방법
|
|
US11260132B2
(en)
|
2017-03-16 |
2022-03-01 |
Children's Medical Center Corporation |
Engineered liposomes as cancer-targeted therapeutics
|
|
CN110582282A
(zh)
|
2017-04-25 |
2019-12-17 |
佐剂技术公司 |
三萜皂苷类似物
|
|
JP2020536946A
(ja)
|
2017-10-16 |
2020-12-17 |
アジュバンス・テクノロジーズ・インコーポレーテッド |
トリテルペンサポニン類似物
|
|
KR102914074B1
(ko)
|
2018-05-18 |
2026-01-16 |
바이오버라티브 테라퓨틱스 인크. |
A형 혈우병의 치료 방법
|
|
JP2020026397A
(ja)
*
|
2018-08-09 |
2020-02-20 |
国立大学法人 岡山大学 |
ＴｒｋＢアンタゴニストを含む医薬組成物
|
|
AU2020379738A1
(en)
|
2019-11-05 |
2022-04-14 |
Adjuvance Technologies, Inc. |
Varicella zoster
|
|
EP4058504A1
(en)
|
2019-11-12 |
2022-09-21 |
DSM IP Assets B.V. |
Polyesteramide copolymers possessing high glass transition temperatures
|
|
PH12022553407A1
(en)
|
2020-06-25 |
2024-04-22 |
Amunix Pharmaceuticals Inc |
Her-2 targeted bispecific compositions and methods for making and using the same
|
|
WO2022204267A1
(en)
|
2021-03-24 |
2022-09-29 |
Alkermes, Inc. |
Upar antibodies and fusion proteins with the same
|
|
AU2022270670A1
(en)
|
2021-05-05 |
2023-11-30 |
Nejat Duzgunes |
Liposome-encapsulated corticosteriods inhibit sars-cov-2 replication and reduces lung inflammation
|
|
AU2023235562B2
(en)
|
2022-03-14 |
2026-07-30 |
Pfizer Inc. |
Methods for producing an adjuvant
|
|
CN120513083A
(zh)
|
2022-12-01 |
2025-08-19 |
辉瑞大药厂 |
肺炎链球菌缀合物疫苗制剂
|
|
TWI909678B
(zh)
|
2023-09-13 |
2025-12-21 |
美商輝瑞股份有限公司 |
產製佐劑之方法
|
|
TW202602467A
(zh)
|
2024-03-11 |
2026-01-16 |
美商輝瑞股份有限公司 |
包含經共軛之大腸桿菌糖的免疫原性組成物及其用途
|
|
WO2026088120A1
(en)
|
2024-10-24 |
2026-04-30 |
Pfizer Inc. |
Lipidated tlr7/8 modulators as adjuvants and uses thereof
|
|
US20260166136A1
(en)
|
2024-12-18 |
2026-06-18 |
Pfizer Inc. |
Immunogenic compositions and uses thereof
|